Everest Organics Reports Significant Profit Growth Amid Declining Net Sales in March 2025

Everest Organics, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending March 2025. The evaluation changes reflect a notable shift in the company's score, which has seen an adjustment to 12 from 8 over the past three months.
The financial results indicate several positive trends for Everest Organics. The Profit After Tax (PAT) for the quarter reached Rs 2.91 crore, marking a significant growth compared to the average PAT of Rs -1.04 crore from the previous four quarters. This represents a substantial turnaround in profitability. Additionally, the Operating Profit to Interest ratio has reached its highest point in the last five quarters at 2.98 times, suggesting an improvement in the company's capacity to manage interest obligations. Furthermore, the Earnings per Share (EPS) has also peaked at Rs 3.00, indicating enhanced earnings for shareholders.

Conversely, the company has faced challenges, particularly in net sales, which totaled Rs 82.98 crore over the latest six months, reflecting a year-on-year decline of 21.07%. This aspect highlights a negative trend in sales performance.

For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.